In ModO patients, SREBP1c and ACC1 expression, genes related to liver lipogenesis, SREBP2 and ABCG1, genes related to lipoprotein secretion, and CPT1α, related to fatty acid oxidation, were increased in NASH vs. SS. Here, SREBF2 is linked to metabolic dysfunction-associated steatohepatitis.